Palo Alto Health Sciences, Inc.(PAHS) is a digital therapeutic company focused on revolutionizing the mental health industry with clinically proven, non-invasive, drug-free solutions. The Company’s first commercial product, Freespira, is a treatment for panic attacks and the symptoms of panic disorder. Freespira is based on over 30 years of clinical research demonstrating that panic disorder has a physiological component – chronic hyperventilation. We developed Freespira to safely and effectively reduce or eliminate panic attacks and the symptoms of panic disorder. PAHS has received regulatory clearance from the U.S. Food and Drug Administration to market Freespira in the United States.